topSkip to main content

Menu, Secondary

Menu Trigger

Menu

University of California San Diego

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus
Researchers at UC San Diego were able to validate a model that predicts time-lagged effects of the solar wind and the dependence on the wind’s velocity
Researchers at UC San Diego have uncovered the atomic makeup of the coronavirus's sugary cloak
"Nanosponges" cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce, per UC San Diego researchers
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
The Convergence Accelerator Office in the Office of Integrative Activities at the National Science Foundation (NSF) has awarded two researchers at the San Diego Supercomputer Center (SDSC) funding to organize COVID-19 information into a transdisciplinary knowledge network that integrates health, pathogen, and environmental data to better track cases to improve analysis and forecasting across the greater San Diego region.
The National Institutes of Health (NIH) has launched a much-anticipated Phase IIb clinical trial to evaluate whether the malaria drug hydroxychloroquine in combination with the antibiotic azithromycin can prevent hospitalization and death from COVID-19, the disease caused by the novel coronavirus 2019 or SARS-CoV-2.
“Nurses make sacrifices every day, but during this unprecedented time they are stepping up, acting courageously and being the force that leads the way in our community,” said Margarita Baggett, chief clinical officer at UC San Diego Health
University of California San Diego is taking the first steps to introduce Return to Learn, a program that aims to test broadly students, faculty and staff on campus on a recurring basis for presence of the novel coronavirus that causes COVID-19.
Researchers at University of California San Diego School of Medicine have launched a new mobile platform to address another serious complication of the novel coronavirus pandemic: stress and anxiety. Called “MyWellnessCheck,” the platform will seek to understand how the SARS-CoV-2 pandemic is affecting mental health on a global scale and identify how certain attitudes and behaviors may help increase positive well-being during a crisis.